TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mean gestational week at the time of interruption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: skeletal muscle mitochondrial content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: substrate oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic valve events
Endpoint domain: Mortality/survival
Primary endpoint: Motor endplate activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interference pattern of EMG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EULAR good response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic pain occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of strong Nup88 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: arginine-stimulated insulin secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: GLP-1, GIP, and glucagon rise during OGTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: morning cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Insertion to abortion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insertion to balloon expulsion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of vaginal bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Degree of pain
Endpoint domain: Adverse events/effects
Primary endpoint: Complete recovery or much improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Recurrence after corticosteroid injection
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in tendon thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: CD-sens values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IgE-ab levels to Cor a 9 and Cor a 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in tryptase > 20%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PaO2/FiO2-ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of postoperative AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxygen desaturation events
Endpoint domain: Adverse events/effects
Primary endpoint: Vomiting episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Emergence phenomena
Endpoint domain: Adverse events/effects
Primary endpoint: RAW total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in vestibular sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Almost painless intercourse
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Total MRS score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of syncope
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deaths by heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Flow-mediated dilatation improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in free plasma homocysteine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Left side bending strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of daily intentions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: fasting intact proinsulin concentration indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction in TOA scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: management of chronic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate to severe dysuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Moderate to severe urgency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Worse quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: BESS error scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of necrotizing enterocolitis
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of coordinated multidisciplinary diabetes team care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Healing at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean observed time to reach maximum concentration values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean terminal half-life of ABT-761
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Population ABT-761 plasma concentration for 50% maximum inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Nottingham Health Profile sleep subparameter
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Colonoscopy completion rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement in asthma knowledge scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease of TBARS concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase of antioxidant enzyme activities (CAT, GSH-Px, SOD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expansion of the capsulorhexis aperture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Agreement of SvO2 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Withdrawal of fondaparinux administration
Endpoint domain: Adverse events/effects
Primary endpoint: Awareness of the government calorie reference value
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PG decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Catastrophic outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with WTR astigmatism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean uncorrected Snellen acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urge urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful coverage of breast/chestwall and CTVn_L2‐4‐interpectoral
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: percentage of communicative space used
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: use of the mediating object
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: breathing pattern during sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: arterial blood gases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: degree of subjective comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recall prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death, myocardial infarction, unstable angina, revascularization, or stroke
Endpoint domain: Mortality/survival
Primary endpoint: Chronic tension-type headaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analgesic medication use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Enzymuria (AAP and NAG levels)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 6-month-confirmed EDSS worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-monitoring of glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPAP pressure in MAS responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depression rate of change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cure (healed wound) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sinus tract closure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of new or enlarging T2 lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Risk of confirmed disability worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Blood NfL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of stay at first admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lost work days after discharge
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Left Atrial Ejection Fraction (LAEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: overall understanding of prognosis, treatment options, risks, and benefits
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean total analgesic dose
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: recurrence of hemorrhoids
Endpoint domain: Mortality/survival
Primary endpoint: Risk for any SPTs
Endpoint domain: Mortality/survival
Primary endpoint: Risk for tobacco-related SPTs
Endpoint domain: Mortality/survival
Primary endpoint: Global improvement as rated by parents
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Conduct problems and hyperactivity factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety as rated on Conners' Parent Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean relative change in S-oligo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean relative change in 3MSCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of TEMH
Endpoint domain: Adverse events/effects
Primary endpoint: Shivers
Endpoint domain: Adverse events/effects
Primary endpoint: RANKL to OPG ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Transmission of HIV-1 through breastfeeding
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of severe anemia (hemoglobin <10 g/dL)
Endpoint domain: Adverse events/effects
Primary endpoint: CFF (Critical Flicker Fusion)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Target to background ratio (TBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calcification progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: positive states of mind
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acceptability of FDC for children
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: TRAP5b
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dCA normalised gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: VLDL-apoB concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: VLDL-apoB secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: circulating IGF-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: WOOS (Western Ontario and McMaster Universities Osteoarthritis Index)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: combined endpoint of unexpected battery depletion, infection, and device dysfunction
Endpoint domain: Adverse events/effects
Primary endpoint: Mean DLT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute scotoma sizes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active metabolite exposure to clopidogrel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VASP platelet reactivity index (PRI, %)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VerifyNow P2Y12 reaction unit (PRU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uterine bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: marital functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: sexual functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean cardiac output change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Arterial pH change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma ionized calcium change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: severe hypoglycemia events/person-year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clarke score (hypoglycemia awareness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Granuloma detection yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedation requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Preference for nurse-midwife consultation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness of medical TOP provision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAI-1:Ag concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: tPA:Ag level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: E-1 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: CO(2)‐induced subjective distress and breathlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: electrocardiogram findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood lactate concentration difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Sensitivity for identifying small glaucomatous discs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity for identifying small glaucomatous discs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of urgency episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of urinary incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6 minute walk test distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative dentofacial growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Day-60 mortality
Endpoint domain: Mortality/survival
Primary endpoint: Days of invasive ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (RAND-36 General Health Status)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Depth of anesthesia (BIS value)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulatory system function stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Objective function values (OFV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-segment late luminal loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Persistence of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum osmolal gap
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum disaccharide (maltose) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of bone mineral content in the lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Oral clearance of fexofenadine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CYP2C9 function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: calories consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Irritable bowel syndrome symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Serum levels of proinflammatory IL-6 and IL-8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of fecal bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: knowledge regarding leisure-time walking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: guidance regarding leisure-time walking
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: guidance regarding healthy eating
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: complete control of vertigo (class A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: substantial control of vertigo (class B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hearing preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative serum ALT and total bilirubin (TBIL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced insulin exposure (AUC(0‐t'))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reduced total insulin effect (total glucose infusion rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Level of motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean aortic enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interpatient variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in correct responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: grade 2 onycholysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: all grade onycholysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Total health care costs at 2 years
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Lasofoxifene C(max) and AUC ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TSSE performance
Endpoint domain: Mortality/survival
Primary endpoint: Medial antebrachial cutaneous amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: RBC volume expansion (mL per kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pain coping skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: major recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of target lesion revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Performance in diathermy tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: clinical ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total body mass increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Squat 1-RM increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of early beta-blocker therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maternal depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Abnormal endometrial biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Duration until next treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention